3 products found
JW Holdings Products
-
Model SMEDDS - Incrementally Modified Drugs (IMD)
Self-microemulsifying drug delivery system (SMEDDS) is a solubilization technology for improving bioavailability of poorly soluble drugs. By combining surfactant and co-surfactant with a poorly soluble drug, this technology improves the bioavailability of the drug by forming fine emulsion droplets upon dilution with physiological fluid after administration. This proprietary technology utilized SMEDDS technology to solubilize the poorly soluble drug, and ...
-
DC Vaccine Technology
DC vaccine derived from patient’s own blood cells is the personalized immunotherapeutic vaccine for cancer and auto-immune diseases. Disease specific antigens-loaded dendritic cell allows the immune cells to recognize and attack only cancer cells through a tumor specific antigen recognition ...
-
Cytoplasmic Transduction Peptide (CTP) Technology
CTP (Cytoplasmic Transduction Peptide) Technology is effective drug delivery system that ensure the cytoplasmic delivery of the CTP-fused polymeric ...